The reason for the increase loss is because of the 65 million from eisai did not hit q4..JL has already said that at the q3 cc, this is no big deal the 65 million will hit Q1 plus launch revs..Remember when one thinks WS will act one way they act another, so maybe a sell off is not in the works at all, plus JL has never moved a cc up two weeks and before the market opens
Arena Pharmaceuticals had a loss of 10 cents for the 4th quarter of 2012.
This compares to analysts concensus estimate of a loss of 3 cents.
The lowest analyst estimate for Arena was a loss of 10 cents versus the highest analyst estimate of a profit of 21 cents.
Arenas revenues for the 4th quarter of 2012 were 1.9 million dollars, far below the analysts concensus of 21 million dollars, and even a tad bit below the lowest revenue estimate of 2 million dollars.